ELNORIL
"ELNORIL" is a word mark owned by Exeltis Healthcare, S.L., filed at the EUIPO on July 17, 2026. It is in its opposition period and covers class 5 (Pharmaceuticals).
- Status
- Opposition period
- Since September 23, 2026
- Filed
- July 17, 2026
- Registered
- Not yet
- Expires
- Not recorded
- Application no.
- 019396820
- Registration no.
- Not yet
- Office
- EUIPO
- European Union Intellectual Property Office
- Mark type
- Word mark
- 1 class
Who owns ELNORIL
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Exeltis Healthcare, S.L.
Representative
Afianza Asesores, S.L.U.
Afianza Asesores, S.L.U
What the mark covers
The products and services ELNORIL is filed for, grouped by Nice class.
Medicines for inducing sleep and Dietary supplements for promoting sleep
What has happened so far
Steps recorded by the EUIPO, newest first.
- Bulletin 2026/181 Section A.1
About ELNORIL
Who owns the trademark "ELNORIL"?
The EUIPO trademark "ELNORIL" (application 019396820) is owned by Exeltis Healthcare, S.L.
What is the status of "ELNORIL"?
Its status at the EUIPO is: opposition period.
Get this data via the API
Everything on this page comes from the Signa API. Pull ELNORIL and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019f740a-f12b-735f-8442-080f665d085b
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019f740a-f12b-735f-8442-080f665d085b",
"object": "trademark",
"mark_text": "ELNORIL",
"status": {
"primary": "pending",
"stage": "pending_opposition"
},
"office_code": "EM",
"application_number": "019396820",
"filing_date": "2026-07-17",
"nice_classes": [
5
],
"owners": [
{
"name": "EXELTIS HEALTHCARE, S.L.",
"entity_id": "ent_019eb7cd-2577-74ba-9d9b-b09a5f2aa924"
}
]
}